These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15172156)

  • 1. Folate receptor-mediated targeting of liposomal drugs to cancer cells.
    Stephenson SM; Low PS; Lee RJ
    Methods Enzymol; 2004; 387():33-50. PubMed ID: 15172156
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
    Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
    Leamon CP; Cooper SR; Hardee GE
    Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
    Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
    Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
    Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Folate receptor-mediated antitumor drugs].
    Zhao J; Cao SL; Zheng XL; Zhao B
    Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
    Gabizon A; Shmeeda H; Horowitz AT; Zalipsky S
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1177-92. PubMed ID: 15094214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
    Ni S; Stephenson SM; Lee RJ
    Anticancer Res; 2002; 22(4):2131-5. PubMed ID: 12174894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of a novel lipophilic folate receptor targeting ligand.
    Liu Y; Xu S; Teng L; Yung B; Zhu J; Ding H; Lee RJ
    Anticancer Res; 2011 May; 31(5):1521-5. PubMed ID: 21617205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
    Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
    Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cancer cell-specific apoptosis by folate-labeled cationic liposomes.
    Yoshida T; Oide N; Sakamoto T; Yotsumoto S; Negishi Y; Tsuchiya S; Aramaki Y
    J Control Release; 2006 Apr; 111(3):325-32. PubMed ID: 16478640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate targeting of drug carriers: a mathematical model.
    Ghaghada KB; Saul J; Natarajan JV; Bellamkonda RV; Annapragada AV
    J Control Release; 2005 May; 104(1):113-28. PubMed ID: 15866339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
    Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
    J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone.
    Kawano K; Onose E; Hattori Y; Maitani Y
    Mol Pharm; 2009; 6(1):98-104. PubMed ID: 19072653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated oligodeoxynucleotides delivery by estradiol and folic acid polylysine conjugates.
    Citro G; Ginobbi P; Szczylik C
    Cytotechnology; 1993; 11 Suppl 1():S30-4. PubMed ID: 7764059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells.
    Viola-Villegas N; Rabideau AE; Cesnavicious J; Zubieta J; Doyle RP
    ChemMedChem; 2008 Sep; 3(9):1387-94. PubMed ID: 18651631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
    Wang Y; Zhao R; Goldman ID
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma.
    Turk MJ; Waters DJ; Low PS
    Cancer Lett; 2004 Sep; 213(2):165-72. PubMed ID: 15327831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.